Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Year-over-year net income growth rate
Percentile
P3
Near historical low
vs 3Y Ago
-27.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2367.41% |
| Q3 2025 | 118.62% |
| Q2 2025 | -95.96% |
| Q1 2025 | 126.80% |
| Q4 2024 | -13.80% |
| Q3 2024 | -133.50% |
| Q2 2024 | 52.28% |
| Q1 2024 | -3029.15% |
| Q4 2023 | 104.24% |
| Q3 2023 | -29.69% |
| Q2 2023 | 58.43% |
| Q1 2023 | -255.88% |
| Q4 2022 | 86.04% |
| Q3 2022 | -283.69% |
| Q2 2022 | 147.18% |
| Q1 2022 | 10.65% |
| Q4 2021 | -17.33% |
| Q3 2021 | 28.29% |
| Q2 2021 | -19.34% |
| Q1 2021 | 20.02% |
| Q4 2020 | -45.10% |
| Q3 2020 | 65.88% |
| Q2 2020 | -189.32% |
| Q1 2020 | 35.71% |
| Q4 2019 | -73.09% |
| Q3 2019 | 6.16% |
| Q2 2019 | 19.68% |
| Q1 2019 | 18.05% |
| Q4 2018 | -239.27% |
| Q3 2018 | 23.55% |
| Q2 2018 | -45.48% |
| Q1 2018 | -290.70% |
| Q4 2017 | 153.08% |
| Q3 2017 | -7.51% |
| Q2 2017 | 51.69% |
| Q1 2017 | -17.65% |
| Q4 2016 | -4.28% |
| Q3 2016 | -1.48% |
| Q2 2016 | -38.69% |
| Q1 2016 | -29.92% |